67 related articles for article (PubMed ID: 26757543)
21. Molecular Architecture of the Retroviral Capsid.
Perilla JR; Gronenborn AM
Trends Biochem Sci; 2016 May; 41(5):410-420. PubMed ID: 27039020
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid.
Kong J; Xu B; Wei W; Wang X; Xie W; Yu XF
Protein Cell; 2014 Dec; 5(12):954-7. PubMed ID: 25363729
[No Abstract] [Full Text] [Related]
23. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
24. Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution.
Schur FK; Hagen WJ; Rumlová M; Ruml T; Müller B; Kräusslich HG; Briggs JA
Nature; 2015 Jan; 517(7535):505-8. PubMed ID: 25363765
[TBL] [Abstract][Full Text] [Related]
25. Dynamic allostery governs cyclophilin A-HIV capsid interplay.
Lu M; Hou G; Zhang H; Suiter CL; Ahn J; Byeon IJ; Perilla JR; Langmead CJ; Hung I; Gor'kov PL; Gan Z; Brey W; Aiken C; Zhang P; Schulten K; Gronenborn AM; Polenova T
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14617-22. PubMed ID: 26553990
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Early Step of Building Block Organization in Viral Capsid Assembly.
Lampel A; Bram Y; Ezer A; Shaltiel-Kario R; Saad JS; Bacharach E; Gazit E
ACS Chem Biol; 2015 Aug; 10(8):1785-90. PubMed ID: 25997366
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence Biosensor for Real-Time Interaction Dynamics of Host Proteins with HIV-1 Capsid Tubes.
Lau D; Walsh JC; Peng W; Shah VB; Turville S; Jacques DA; Böcking T
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34586-34594. PubMed ID: 31483592
[TBL] [Abstract][Full Text] [Related]
28. A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization.
Lemke CT; Titolo S; Goudreau N; Faucher AM; Mason SW; Bonneau P
Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1115-23. PubMed ID: 23695256
[TBL] [Abstract][Full Text] [Related]
29. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Hulme AE; Kelley Z; Foley D; Hope TJ
J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes.
Ehrlich LS; Liu T; Scarlata S; Chu B; Carter CA
Biophys J; 2001 Jul; 81(1):586-94. PubMed ID: 11423440
[TBL] [Abstract][Full Text] [Related]
31. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
32. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein.
Cornilescu CC; Bouamr F; Yao X; Carter C; Tjandra N
J Mol Biol; 2001 Mar; 306(4):783-97. PubMed ID: 11243788
[TBL] [Abstract][Full Text] [Related]
33. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.
Worthylake DK; Wang H; Yoo S; Sundquist WI; Hill CP
Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):85-92. PubMed ID: 10089398
[TBL] [Abstract][Full Text] [Related]
34. Modeling HIV-1 viral capsid nucleation by dynamical systems.
Sadre-Marandi F; Liu Y; Liu J; Tavener S; Zou X
Math Biosci; 2015 Dec; 270(Pt A):95-105. PubMed ID: 26596714
[TBL] [Abstract][Full Text] [Related]
35. Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy.
Veselovsky AV; Zharkova MS; Poroikov VV; Nicklaus MC
SAR QSAR Environ Res; 2014; 25(6):457-71. PubMed ID: 24716798
[TBL] [Abstract][Full Text] [Related]
36. Quantification and modification of the equilibrium dynamics and mechanics of a viral capsid lattice self-assembled as a protein nanocoating.
Valbuena A; Mateu MG
Nanoscale; 2015 Sep; 7(36):14953-64. PubMed ID: 26302823
[TBL] [Abstract][Full Text] [Related]
37. Capsid proteins of enveloped viruses as antiviral drug targets.
Klumpp K; Crépin T
Curr Opin Virol; 2014 Apr; 5():63-71. PubMed ID: 24607800
[TBL] [Abstract][Full Text] [Related]
38. Stem of SL1 RNA in HIV-1: structure and nucleocapsid protein binding for a 1 x 3 internal loop.
Yuan Y; Kerwood DJ; Paoletti AC; Shubsda MF; Borer PN
Biochemistry; 2003 May; 42(18):5259-69. PubMed ID: 12731867
[TBL] [Abstract][Full Text] [Related]
39. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.
Bosco DA; Eisenmesser EZ; Pochapsky S; Sundquist WI; Kern D
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5247-52. PubMed ID: 11929983
[TBL] [Abstract][Full Text] [Related]
40. Drug discovery: engineering drug combinations.
Dixon SJ; Stockwell BR
Nat Chem Biol; 2010 May; 6(5):318-9. PubMed ID: 20404820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
